AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be attending the Investor Conference as per below details. AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below. AARTI DRUGS LTD. - 524348 - Disclosure Of Related Party Transactions For Half Year Ended March 31, 2021
In compliance with Regulation 23(9) of SEBI (LODR) Regulations, 2015 we enclose disclosure of Related Party Transactions on a consolidated basis for the half year ended March 31, 2021. Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be attending the Investor Conference as per below details. Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below. Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find attached herewith transcript of Q4 FY21 Earning Conference Call. AARTI DRUGS LTD. - 524348 - Corporate Action-Updates on Buy back
In compliance with SEBI (Buy-back of Securities) Regulations, 2018 ('Buy-back Regulations') this is to inform you that Company has extinguished 6,00,000 Equity Shares. Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the Copies of newspaper advertisement published in Financial Express (English) and Aapla Mahanagar (Marathi). This is pursuant to Section 124(6) of the Companies Act, 2013 read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended regarding transfer of equity shares to the Investor Education and Protection Fund. AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Post Buyback Public Announcement
Pursuant to the applicable provisions of the SEBI Listing Regulations, we enclose the copies of newspaper advertisement published in Financial Express, Navshakti (Marathi) and Jansatta (Hindi) regarding Post Buyback Public Announcement. AARTI DRUGS LTD. - 524348 - Post Buyback Public Announcement
Inga Ventures Pvt Ltd ("Manager to the Buyback Offer") has submitted to BSE a copy of Post Buyback Public Announcement for the attention of Equity Shareholders / Beneficial owners of Equity Shares of Aarti Drugs Ltd ("Target Company").